Related Experiment Video
Updated: Sep 27, 2025
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Exosomes as versatile nanoscaled biocompartments in cancer therapy and/or resistance
Yalda Rahbar Saadat1,2, Jaleh Barar1,3
1Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:
Cancer remains to be a major hurdle to global health. Exosomes as a versatile bio-derived platform, hold a bright prospect in nano-scaled delivery/targeting strategies. Shreds of evidence indicate that exosomes have a critical role in drug resistance in cancer cells through various mechanisms including shuttling of miRNAs, drug efflux transporters, and anti-apoptotic signaling. Exosomes' cargo, particularly miRNAs, may exert both resistance and in a few cases sensitivity to the anticancer agents in targeted cells. Therefore, the source and components of the exosomes should be carefully considered before any application. Our aim in this editorial is to further highlight the role of exosomes in the development of resistance to therapy in cancer cells. As a new chapter for drug delivery, the challenges should be elucidated before exosomes emerge as novel nanoplatforms for cancer therapy.
Insights
Exosomes play a key role in cancer drug resistance by transporting molecules like miRNAs. Careful consideration of exosome cargo and source is crucial for effective cancer therapy development.
Area of Science:
- Oncology
- Nanotechnology
- Molecular Biology
Background:
- Cancer poses a significant global health challenge.
- Exosomes, nanoscale vesicles, show promise for drug delivery and targeting.
- Exosomes are implicated in cancer drug resistance via various mechanisms.
Discussion:
- Exosomes contribute to cancer drug resistance via mechanisms like miRNA shuttling, drug efflux transporter delivery, and modulation of anti-apoptotic signaling.
- The cargo within exosomes, especially microRNAs (miRNAs), can influence cellular sensitivity or resistance to anticancer agents.
- Understanding the origin and composition of exosomes is vital before their therapeutic application.
Key Insights:
- Exosomes are implicated in the development of resistance to cancer therapies.
- Exosome cargo, particularly miRNAs, can dictate treatment response in cancer cells.
- Therapeutic strategies utilizing exosomes must account for their dual role in drug sensitivity and resistance.
Outlook:
- Further research is needed to elucidate the challenges associated with using exosomes as cancer nanotherapeutics.
- Careful characterization of exosome sources and contents is essential for successful clinical translation.
- Addressing the complexities of exosome-mediated drug resistance is critical for advancing exosome-based cancer treatments.
Related Concept Videos
01:36Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
01:19Mesenchymal Stem Cells
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...